| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01XJ03 |
| UNII: | K673DMO5H9 |
| InChI Key | SFNSLLSYNZWZQG-VQIMIIECSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H22N6O |
| Molecular Weight | 374.45 |
| AlogP | 3.39 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 96.84 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Smoothened homolog antagonist | Other |
| Primary Target | |
|---|---|
| SMO |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Frizzled family G protein-coupled receptor
Smoothened receptor (frizzled family GPCR)
|
- | 5 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Sarcoma | 3 | D012509 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1095173-27-5 |
| ChEBI | 145428 |
| ChEMBL | CHEMBL2043437 |
| DrugBank | DB11978 |
| DrugCentral | 5304 |
| FDA SRS | K673DMO5H9 |
| Guide to Pharmacology | 8201 |
| PubChem | 25166913 |
| SureChEMBL | SCHEMBL2068480 |
| ZINC | ZINC000068251434 |